Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone.
母体 MitoQ 治疗可预防产前地塞米松引起的 CYP 活性程序性改变
期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17030285
Bennett Millicent G A, Meakin Ashley S, Botting-Lawford Kimberley J, Niu Youguo, Ford Sage G, Murphy Michael P, Wiese Michael D, Giussani Dino A, Morrison Janna L
